Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection. - Rajat Desikan; Rubesh Raja; Narendra M. Dixit (PLoS Comput. Biol., 2020)

Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection. - Pranesh Padmanabhan; Rajat Desikan; Narendra M. Dixit (PLoS Comput. Biol., 2020)

Modeling how antibody responses may determine the efficacy of COVID-19 vaccines. - Pranesh Padmanabhan; Rajat Desikan; Narendra M. Dixit (Nat. Comput. Sci., 2022)